Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Aug 19, 2026, 12:39 PM EST
Waverley Pharma Market Cap
Waverley Pharma has a market cap or net worth of CAD 810 thousand as of August 20, 2026.
Market Cap
810.00K
Enterprise Value
4.28M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since October 27, 2017, Waverley Pharma's market cap has decreased from 27.00M to 810.00K, a decrease of -97.00%. That is a compound annual growth rate of -32.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 810.00K | -25.00% |
| Dec 22, 2025 | 1.08M | 100.00% |
| Dec 31, 2024 | 540.00K | -60.00% |
| Dec 22, 2023 | 1.35M | -16.67% |
| Dec 28, 2022 | 1.62M | -62.50% |
| Dec 30, 2021 | 4.32M | -36.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioVaxys Technology | 3.09M |
| Universal Ibogaine | 1.56M |
| MindBio Therapeutics | 1.53M |
| Doseology Sciences | 1.40M |
| Appili Therapeutics | 1.32M |
| ASEP Medical Holdings | 873.04K |
| Vaxil Bio | 637.44K |
| ChitogenX | 415.65K |